Five Prime Therapeutics announced restructuring plans that will involve eliminating 41 jobs, representing about 20 percent of its current headcount, mainly in the areas of research, pathology and manufacturing.
Five Prime Therapeutics announced restructuring plans that will involve eliminating 41 jobs, representing about 20 percent of its current headcount, mainly in the areas of research, pathology and manufacturing.